Genzyme Corporation (GENZ) Completes Acquisition Of ILEX Oncology, Inc. (GENZ)
10/19/2005 5:12:30 PM
More...
|
Additional Patients Support Clofarabine Promise; ILEX Oncology, Inc. (ILXO) Expects FDA Decision On NDA Filing By Year End
10/19/2005 5:12:23 PM
More...
|
Bioenvision (BIOV) Release: Clofarabine Achieves High Response Rates In Acute Myeloid Leukaemia -AML-; Three Fold Increase In Response Rates Compared With Current Standard Of Care
10/19/2005 5:12:22 PM
More...
|
ILEX Oncology, Inc. (ILXO) Drug Helps One Leukemia, Not Another -US Panel
10/19/2005 5:12:21 PM
More...
|
ILEX Oncology, Inc. (ILXO) Release: FDA Advisory Committee Recommends Accelerated Clofarabine Approval For Most Common Pediatric Leukemia
10/19/2005 5:12:20 PM
More...
|
FDAAdvisoryCommittee.com To Webcast Dec. 1-2 Reviews Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa, ILEX Oncology, Inc.' (ILXO) Clolar For Leukemia, And INEX Pharmaceuticals (IEX.TO) / Enzon Pharmaceuticals, Inc.'s (ENZN) Marqibo For Lymphoma
10/19/2005 5:12:19 PM
More...
|
ILEX Oncology (ILXO) Reports Q3 2004 Results; Clofarabine FDA Panel Hearing Set For December
10/19/2005 5:11:52 PM
More...
|
Berlex Inc. And ILEX Oncology (ILXO) Release: CAMPATH(R) (Alemtuzumab For Injection) Approved For Marketing In New Single-Use Vial
10/19/2005 5:11:51 PM
More...
|
Bioenvision's (BIOV) Clofarabine Data Presented At Leading Hematology Congress; Durable Responses Reported At Leukemia 2004 Houston, Texas
10/19/2005 5:11:49 PM
More...
|
ILEX Oncology (ILXO) Updates Clofarabine NDA With Encouraging Results; Additional Patient Data Resets FDA Action Date
10/19/2005 5:11:41 PM
More...
|
|